Deciphering the therapeutic potential of bergenin in breast cancer: In silico insights into HSP90AA1 and HRAS interaction mediated inhibition of PI3K-Akt and MAPK signaling pathway. IJBB [Internet]. 2024 Oct. 11 [cited 2026 May 13];61(11):639-58. Available from: https://or.niscpr.res.in/index.php/IJBB/article/view/6391